AML

Article

COVID-19 mortality higher in patients with active AML vs. those in remission

• Read More

Article

Allo-HSCT in CR1 beneficial for elderly AML patients with unfavorable or intermediate-risk cytogenetics

• Read More

Article

Varied outcomes in AML patients with NPM-mutant MRD+ at end of IC

• Read More

Article

LDAC+venetoclax shows promise as frontline therapy in treatment-naive AML patients unfit for IC

• Read More

Article

R/R AML: Mito-FLAG improves response, but allo-HSCT remains essential for prolonged survival

• Read More

Article

Intensification of induction II does not improve outcomes in pediatric high-risk AML

• Read More

Article

Addition of quizartinib to LDAC improves outcomes in older patients with FLT3-ITD-mutated AML

• Read More

Conference Coverage

HMAs benefit children with relapsed/refractory AML

Author:

Neil Osterweil

Azacitidine and decitabine alone or in combination may help children and young adults reach stem cell transplant...

• Read More

Conference Coverage

Reduced-intensity transplant benefits older patients with AML

Author:

Nancy A. Melville

This improvement in survival is seen regardless of key factors such as genotype and the status of minimal...

• Read More

Conference Coverage

Pediatric cancer survivors at risk for opioid misuse

Author:

Neil Osterweil

In the first year after the end of treatment, survivors of childhood cancers were at significantly greater risk...

• Read More

From the Journals

Mitochondrial DNA predicts survival in pediatric acute myeloid leukemia

Author:

Mark S. Lesney, PhD

Genetic analysis showed that the mitochondrial biogenesis gene PGC1A may have a possible role in increasing...

• Read More